- Home
- NXPL vs PMN Comparison
NXPL vs PMN Comparison
Compare NXPL & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXPL
- PMN
- Stock Information
- Founded
- NXPL 1997
- PMN 2004
- Country
- NXPL United States
- PMN Canada
- Employees
- NXPL N/A
- PMN N/A
- Industry
- NXPL Telecommunications Equipment
- PMN Pharmaceuticals and Biotechnology
- Sector
- NXPL Telecommunications
- PMN Health Care
- Exchange
- NXPL Nasdaq
- PMN Nasdaq
- Market Cap
- NXPL 17.9M
- PMN 17.0M
- IPO Year
- NXPL N/A
- PMN N/A
- Fundamental
- Price
- NXPL $0.77
- PMN $0.41
- Analyst Decision
- NXPL
- PMN Strong Buy
- Analyst Count
- NXPL 0
- PMN 2
- Target Price
- NXPL N/A
- PMN $4.50
- AVG Volume (30 Days)
- NXPL 30.1K
- PMN 53.3K
- Earning Date
- NXPL 08-13-2025
- PMN 08-07-2025
- Dividend Yield
- NXPL N/A
- PMN N/A
- EPS Growth
- NXPL N/A
- PMN N/A
- EPS
- NXPL N/A
- PMN N/A
- Revenue
- NXPL $62,515,000.00
- PMN N/A
- Revenue This Year
- NXPL N/A
- PMN N/A
- Revenue Next Year
- NXPL N/A
- PMN N/A
- P/E Ratio
- NXPL N/A
- PMN N/A
- Revenue Growth
- NXPL 19.36
- PMN N/A
- 52 Week Low
- NXPL $0.43
- PMN $0.38
- 52 Week High
- NXPL $2.30
- PMN $2.37
- Technical
- Relative Strength Index (RSI)
- NXPL 60.63
- PMN 33.26
- Support Level
- NXPL $0.73
- PMN $0.48
- Resistance Level
- NXPL $0.85
- PMN $0.50
- Average True Range (ATR)
- NXPL 0.06
- PMN 0.03
- MACD
- NXPL 0.00
- PMN -0.01
- Stochastic Oscillator
- NXPL 60.00
- PMN 24.54
About NXPL NextPlat Corp
NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.